Retrieve available abstracts of 116 articles: HTML format
Single Articles
May 2025
XU X, Zhang Y, Wu S, Wu Y, et al Hepatitis B Virus Promotes Angiogenesis in Hepatocellular Carcinoma by Increasing
m6A Modification of VEGFA mRNA via IGF2BP3.
J Med Virol. 2025;97:e70356. PubMedAbstract available
HUANG L, Ye B, Cao F, Ruan B, et al Single-Cell Atlas of the Peripheral Immune Response in Patients With Chronic
Hepatitis B.
J Med Virol. 2025;97:e70360. PubMedAbstract available
KILLER A, Gliga S, Jensen BO, Park P, et al Functional Cure of Hepatitis B and D Coinfection After ART Nonadherence in a
Person With HIV.
J Med Virol. 2025;97:e70375. PubMed
YE X, Xu X, Dang Y, Zeng J, et al High Genetic Variability of Hepatitis B Virus in Blood Donors With Surface
Antigen Positive But DNA Negative in Southern China.
J Med Virol. 2025;97:e70396. PubMedAbstract available
April 2025
FANG Z, Wang C, Huang CL, Tan D, et al Extrathymic CD8 and CD4 Double Positive T Cells Presenting Vigorous HBV-Specific
Responses Accelerate HBV Clearance.
J Med Virol. 2025;97:e70303. PubMedAbstract available
WAN Q, Yu X, Huang J, Yang L, et al An Investigative Study of LGALSL and HLA-DRB1 as Prognostic Biomarkers and
Therapeutic Targets in Chronic Hepatitis B Patients With Persistent HBV DNA
Viremia Under Entecavir Treatment.
J Med Virol. 2025;97:e70329. PubMedAbstract available
YE L, Ouyang W, Gu Y, Yao Z, et al HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients
With Chronic Hepatitis B.
J Med Virol. 2025;97:e70350. PubMedAbstract available
HSU PY, Su HC, Ma MC, Chen CA, et al Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B
Patients: Systematic Review and Meta-Analysis.
J Med Virol. 2025;97:e70331. PubMedAbstract available
DENG Y, Zheng J, Li F, Zou H, et al Hepatocyte-Enriched miRNA-193b-3p Promotes Hepatitis B Virus Replication by Dual
Activation of Viral Core Promoter Activity and Autophagy Induction by Targeting
IGF-1R.
J Med Virol. 2025;97:e70330. PubMedAbstract available
March 2025
WU BY, Tian YX, Zuo J, Yang JR, et al Global, Regional, and National Burdens of Hepatitis E From 1990 to 2021 and
Predicted 2030 Incidence: Results From the Global Burden of Disease Study 2021.
J Med Virol. 2025;97:e70279. PubMedAbstract available
JIANG Q, Zhou Z, Du X, Li Y, et al Novel Function of NUP153 in HNF4alpha Transcriptional Upregulation Contributes to
Promoting HBV Replication.
J Med Virol. 2025;97:e70256. PubMedAbstract available
MIAO X, Zhou X, Liu C, Shi H, et al Alcohol-Induced Dendritic Cells and Their Exosomes Promote T-Cell Immunity in
Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B.
J Med Virol. 2025;97:e70287. PubMedAbstract available
JIN Q, Zhou M, Sun M, Ning B, et al Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among
Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021
Data.
J Med Virol. 2025;97:e70283. PubMedAbstract available
LIU HN, Lin SY, Ramirez R, Chen SE, et al Development of an NGS-Based Estimation of Integrated HBV DNA in Liver Biopsies
and Detection in Liquid Biopsies.
J Med Virol. 2025;97:e70290. PubMedAbstract available
XIE ZQ, Tan WL, Wang ZM, Kang Y, et al HBx/DTL Positive Feedback Loop Promotes HBV-Related Hepatocellular Carcinoma
Progression.
J Med Virol. 2025;97:e70284. PubMedAbstract available
CHIANG CM, Lin YJ, Liu WC, Chou TC, et al HBV Recurrence Detected by HBV-Related Serum Markers and Immune Escape Mutations
in Chronic Hepatitis B Patients Following Liver Transplantation.
J Med Virol. 2025;97:e70306. PubMedAbstract available
XIA W, Tan Y, Mei B, Zhou Y, et al Application of Interpretable Machine Learning Models to Predict the Risk Factors
of HBV-Related Liver Cirrhosis in CHB Patients Based on Routine Clinical Data: A
Retrospective Cohort Study.
J Med Virol. 2025;97:e70302. PubMedAbstract available
PONNUVEL S, Ali H, Prakash A, John Steve R, et al Superior Performance of Newly Developed Alinity Anti-HCV Next Assay in the
Diagnosis of HCV Infection.
J Med Virol. 2025;97:e70307. PubMedAbstract available
February 2025
LUZ E, Marques M, Arriaga MB, Campos LM, et al Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
J Med Virol. 2025;97:e70186. PubMedAbstract available
LIU Q, Huang J, Hu J, Ding Y, et al The Effect of HBV Therapy on Glycemic Control in HBV-Infected Patients With
Diabetes: A 90-day Multicenter Study.
J Med Virol. 2025;97:e70185. PubMedAbstract available
KIM LY, Kim JY, Yoo JJ, Kim SG, et al Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and
Cardiovascular Outcomes in People Living With Chronic Hepatitis B.
J Med Virol. 2025;97:e70187. PubMedAbstract available
ZHANG F, Shi Z, Wu Y, Xia J, et al Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against
Hepatitis E Virus Infection in Rabbits.
J Med Virol. 2025;97:e70218. PubMedAbstract available
CHOI YM, Kim DH, Cho EJ, Kim Z, et al The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced
Viral Replication and Apoptotic Cell Death Induced by PERK-eIF2alpha-CHOP-Mediated ER
Stress.
J Med Virol. 2025;97:e70253. PubMedAbstract available
ARSLAN N, Reuter B, Buech J, Lengauer T, et al Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning
Methods.
J Med Virol. 2025;97:e70169. PubMedAbstract available
January 2025
LIU M, Yuan M, Ma Y, Wang J, et al Wild-Type and rtA181T/sW172* Mutant Strains of Hepatitis B Virus Drive
Hepatocarcinogenesis via Distinct GRP78-Mediated ER Stress Pathways.
J Med Virol. 2025;97:e70151. PubMedAbstract available
Correction to "Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain".
J Med Virol. 2025;97:e70152. PubMed
December 2024
FAN Z, Xu L, Cao Y, Liu T, et al One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care
Testing.
J Med Virol. 2024;96:e70115. PubMedAbstract available
KAMBOJ S, Kumar M Global Origin and Spatiotemporal Spread of Hepatitis C Virus Epidemic
Genotypes/Subtypes: A Complete Genome-Based Phylodynamic and Phylogeographic
Analyses.
J Med Virol. 2024;96:e70123. PubMedAbstract available
LI Z, Rahman N, Bi C, Mohallem R, et al RNA Helicase DDX5 in Association With IFI16 and the Polycomb Repressive Complex 2
Silences Transcription of the Hepatitis B Virus by Interferon.
J Med Virol. 2024;96:e70118. PubMedAbstract available
LIN W, He Y, Gu F, Hu F, et al Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg
Seroclearance in HBV/HIV-1 Co-Infection.
J Med Virol. 2024;96:e70114. PubMedAbstract available
ZHANG Y, Luo Q, Lin X, Wang L, et al Development and Validation of a New Model Including Inflammation Indexes for the
Long-Term Prognosis of Hepatitis B-Related Acute-On-Chronic Liver Failure.
J Med Virol. 2024;96:e70110. PubMedAbstract available
November 2024
CHU D, Oh YH, Sung H, Ko DH, et al Simple, direct amplification of RNA-containing paper discs for diagnosing the
hepatitis C virus.
J Med Virol. 2024;96:e29919. PubMedAbstract available
RIBEIRO LB, Reche LA, Nastri ACSS, Malta FM, et al Acute Hepatitis Related to Hepatitis E Virus Genotype 3f Infection in Brazil.
J Med Virol. 2024;96:e70024. PubMedAbstract available
HUANG D, Yuan Z, Wu D, Yuan W, et al HBV Antigen-Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon:
Avoid Virologic Breakthrough and Improve Functional Cure.
J Med Virol. 2024;96:e70021. PubMedAbstract available
GONG G, Xin J, Lou Y, Qiong D, et al Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain.
J Med Virol. 2024;96:e70031. PubMedAbstract available
DONG R, Xue H, Chen L, Jin W, et al Associations of Lipid Profiles With the Onset of HEV-Related Acute Liver Failure:
A Multicenter Cohort Study.
J Med Virol. 2024;96:e70033. PubMedAbstract available
WANG J, Jiang H, Zhang G, Dai X, et al Real-World Pharmacovigilance Study Identifies Drugs Linked to Hepatitis B Virus
Reactivation.
J Med Virol. 2024;96:e70055. PubMedAbstract available
October 2024
MUTIMER D, Atabani SF, Brown M, Logan J, et al Determinants of HBeAg loss during follow-up of a multiethnic pediatric cohort.
J Med Virol. 2024;96:e29936. PubMedAbstract available
HE P, Li J, Wang C, Zhang J, et al Incidence and risk factors of de novo hepatitis E virus infection after receiving
liver transplantation.
J Med Virol. 2024;96:e29939. PubMedAbstract available
TREVINO-NAKOURA A, Sepulveda-Crespo D, Bellon JM, Codina H, et al Diagnostic performance of dried blood spot hepatitis C virus core antigen testing
for hepatitis C screening: A systematic review and meta-analysis.
J Med Virol. 2024;96:e70018. PubMedAbstract available
September 2024
CHEN J, Feng T, Xu Q, Yu X, et al Risk predictive model for the development of hepatocellular carcinoma before
initiating long-term antiviral therapy in patients with chronic hepatitis B virus
infection.
J Med Virol. 2024;96:e29884. PubMedAbstract available
LV Z, Liu L, You J, Zhou P, et al Small HBV surface antigen drives regorafenib resistance in HCC via
KIAA1429-dependent m6A modification of CCR9.
J Med Virol. 2024;96:e29894. PubMedAbstract available
RZYMSKI P, Jibril AT, Rahmah L, Abarikwu SO, et al Is there still hope for the prophylactic hepatitis C vaccine? A review of
different approaches.
J Med Virol. 2024;96:e29900. PubMedAbstract available
August 2024
SAKR AA, Mohamed AA, Ahmed AE, Abdelhaleem AA, et al Biochemical implication of acetylcholine, histamine, IL-18, and interferon-alpha
as diagnostic biomarkers in hepatitis C virus, coronavirus disease 2019, and dual
hepatitis C virus-coronavirus disease 2019 patients.
J Med Virol. 2024;96:e29857. PubMedAbstract available
LI X, Zhou Q, Lu Z, Huang R, et al Association of HLA-DRB1 alleles with status of antibodies to hepatitis B surface
and e antigen.
J Med Virol. 2024;96:e29867. PubMedAbstract available
SU R, Yan L, Jiang B, Li J, et al A novel model based on serum N-glycan markers for evaluating stage of liver
necroinflammation in treatment-naive chronic hepatitis B patients.
J Med Virol. 2024;96:e29863. PubMedAbstract available
July 2024
SHIN H, Lim GS, Yoon JW, Ko Y, et al Metabolic effects and cardiovascular disease risks of antiviral treatments in
patients with chronic hepatitis B.
J Med Virol. 2024;96:e29760. PubMedAbstract available
LI Y, Zeng T, Huang P, Tan W, et al Investigating the role of killer cell immunoglobulin-like receptors and human
leukocyte antigen genetic variants in hepatitis C virus infection.
J Med Virol. 2024;96:e29776. PubMedAbstract available
DENG H, Chen Y, Liang S, Liang X, et al Near full-length genome analysis of HEV 4b subtype in pigs showed a similarity up
to 99.944% compared to a patient in Guangdong province, China.
J Med Virol. 2024;96:e29777. PubMedAbstract available
CASTRO V, Calvo G, Oliveros JC, Perez-Del-Pulgar S, et al Hepatitis C virus-induced differential transcriptional traits in host cells after
persistent infection elimination by direct-acting antivirals in cell culture.
J Med Virol. 2024;96:e29787. PubMedAbstract available
SUZUKI T, Matsuura K, Inoue T, Sasada K, et al Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in
HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients.
J Med Virol. 2024;96:e29816. PubMedAbstract available
ZENG Q, Ren Y, Wang Y, Yang J, et al The nuclear matrix protein HNRNPU restricts hepatitis B virus transcription by
promoting OAS3-based activation of host innate immunity.
J Med Virol. 2024;96:e29805. PubMedAbstract available
SATAKE M, Sugiyama M, Mizokami M, Tanaka J, et al Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult
hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B
surface antigen levels.
J Med Virol. 2024;96:e29823. PubMedAbstract available
SHEN L, Zhang Y, Shi M, Shao L, et al Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen
chemiluminescence immunoassay.
J Med Virol. 2024;96:e29817. PubMedAbstract available
June 2024
LI X, Sun X, Pinpin J, Zhao Q, et al Multifunctional ORF3 protein of hepatitis E virus.
J Med Virol. 2024;96:e29691. PubMedAbstract available
WEN X, Wu X, Sun Y, Zhou J, et al Long-term antiviral therapy is associated with changes in the profile of
transcriptionally active HBV integration in the livers of patients with CHB.
J Med Virol. 2024;96:e29606. PubMedAbstract available
FIGUEROA GB, D'souza S, Pereira HS, Vasudeva G, et al Development of a single-domain antibody to target a G-quadruplex located on the
hepatitis B virus covalently closed circular DNA genome.
J Med Virol. 2024;96:e29692. PubMedAbstract available
ZHENG D, Cheng C, Tang Y, Fang Z, et al Circulating metabolites are associated with persistent elevations of ALT in
patients with chronic hepatitis B with complete viral suppression.
J Med Virol. 2024;96:e29723. PubMedAbstract available
SCHEMMERER M, Bock HH, Schattenberg JM, Huber S, et al Proof of infectivity of hepatitis E virus particles from the ejaculate of
chronically infected patients.
J Med Virol. 2024;96:e29735. PubMedAbstract available
GUO JW, Ho HY, Dai CY, Chen YH, et al Single-tube, single-strip lateral flow assays utilizing loop-mediated isothermal
amplification for simultaneous hepatitis B and C viral detection.
J Med Virol. 2024;96:e29721. PubMedAbstract available
LI G, Liu X, Lu F What is the real sword of HBV precore and basal core promoter mutations piercing
the hepatocyte homeostasis: HBcAg or HBsAg?
J Med Virol. 2024;96:e29745. PubMed
GU F, Zeng K, Lan X, He Y, et al Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV
functional cure in HIV/HBV-co-infected patients with HBsAg loss.
J Med Virol. 2024;96:e29762. PubMedAbstract available
May 2024
WU L, Deng H, Feng X, Xie D, et al Interferon-gamma(+) Th1 activates intrahepatic resident memory T cells to promote
HBsAg loss by inducing M1 macrophage polarization.
J Med Virol. 2024;96:e29627. PubMedAbstract available
PIRALLA A, Giardina F, Ferrari G, Gaiarsa S, et al Molecular characterization of emerging Echovirus 11 (E11) shed light on the
recombinant origin of a variant associated with severe hepatitis in neonates.
J Med Virol. 2024;96:e29658. PubMedAbstract available
LIANG Y, Zhang J, Luo D, Cheng L, et al Deregulation of immune response contributing to fulminant hepatitis in HEV
infected pregnant women.
J Med Virol. 2024;96:e29639. PubMedAbstract available
LI Q, Wen W, Wang Y, Gong T, et al Autophagy-related protein 5 (ATG5) interacts with bone marrow stromal cell
antigen 2 (BST2) to stimulate HBV replication through antagonizing the antiviral
activity of BST2.
J Med Virol. 2024;96:e29659. PubMedAbstract available
LIU CH, Chang YP, Lee JY, Chen CY, et al Four weeks of off-treatment follow-up is sufficient to determine virologic
responses at off-treatment week 12 in patients with hepatitis C virus infection
receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol. 2024;96:e29675. PubMedAbstract available
TAN A, He Y, Zhou Y, Peng X, et al A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B.
J Med Virol. 2024;96:e29661. PubMedAbstract available
LAI X, OuYang W, Li S, Qiu J, et al Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg
seroconversion in children with chronic hepatitis B.
J Med Virol. 2024;96:e29670. PubMedAbstract available
REN F, Zhao S, He X, Lo H, et al Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and
cccDNA transcription.
J Med Virol. 2024;96:e29669. PubMedAbstract available
CHANG YP, Huang CB, Su TH, Liu CJ, et al Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II,
Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis
C virus genotyping.
J Med Virol. 2024;96:e29686. PubMedAbstract available
April 2024
ZHANG Y, Yuan X, Wang J, Han M, et al TRPV4 promotes HBV replication and capsid assembly via methylation modification
of H3K4 and HBc ubiquitin.
J Med Virol. 2024;96:e29510. PubMedAbstract available
Retraction: "Small Interfering RNA Effectively Inhibits Protein Expression and
Negative Strand RNA Synthesis From a Full-Length Hepatitis C Virus Clone".
J Med Virol. 2024;96:e29574. PubMedAbstract available
JIANG B, Wang L, Liu H, Wang L, et al Association of HBV serological markers with host antiviral immune response
relevant hepatic inflammatory damage in chronic HBV infection.
J Med Virol. 2024;96:e29569. PubMedAbstract available
CHEN L, Tao X, Zeng M, Li Y, et al Noninvasive tests maintain high accuracy for advanced fibrosis in chronic
hepatitis B patients with different nomenclatures of steatotic liver disease.
J Med Virol. 2024;96:e29613. PubMedAbstract available
HOU L, Zhao J, Cai L, Jin L, et al HBV PreC interacts with SUV39H1 to induce viral replication by blocking the
proteasomal degradation of viral polymerase.
J Med Virol. 2024;96:e29607. PubMedAbstract available
March 2024
CHEN X, Dong S, Shi Y, Wu Z, et al Biosensor-based multiple cross displacement amplification platform for visual and
rapid identification of hepatitis C virus.
J Med Virol. 2024;96:e29481. PubMedAbstract available
WANG LT, Chen YH, Cheng Y, Fan HL, et al Clinical implications of hepatitis B virus core antigen-mediated immunopathologic
T cell responses in chronic hepatitis B.
J Med Virol. 2024;96:e29515. PubMedAbstract available
YANG J, Xu S, Cheng J, Yin X, et al CXCL10 and its receptor in patients with chronic hepatitis B and their ability to
predict HBeAg seroconversion during antiviral treatment with TDF.
J Med Virol. 2024;96:e29516. PubMedAbstract available
CHEN J, Shen L, Guo Q, Ma S, et al The downregulation of Tapasin in dendritic cell regulates CD8(+) T cell autophagy
to hamper hepatitis B viral clearance in the induced pluripotent stem
cell-derived hepatocyte organoid.
J Med Virol. 2024;96:e29546. PubMedAbstract available
ZHA G, Chen Z, Wu N, Huang T, et al Clinical characteristics and immunogenicity after Omicron breakthrough infection
in patients with chronic hepatitis B infection: A longitudinal observational
study.
J Med Virol. 2024;96:e29548. PubMedAbstract available
MIUMA S, Miyaaki H, Ichikawa T, Matsuzaki T, et al Non-liver-related mortality in the DAA era: Insights from post-SVR patients with
and without previous HCC history.
J Med Virol. 2024;96:e29432. PubMedAbstract available
ZHANG H, Li M, Liu H, Dong Y, et al Juveniles, young adults, and infants with hepatitis B virus infection: A genomic
study.
J Med Virol. 2024;96:e29530. PubMedAbstract available
February 2024
GUO L, Liu JJ, Long SY, Wang PY, et al TIM22 and TIM29 inhibit HBV replication by up-regulating SRSF1 expression.
J Med Virol. 2024;96:e29439. PubMedAbstract available
CHEN B, Xu B, Cui HY, Ma ZH, et al Comparison of effectiveness and cost of different HCV testing strategies in
high-risk populations in China.
J Med Virol. 2024;96:e29433. PubMedAbstract available
LU X, Li W, Deng R, Zhou B, et al Serum hepatitis B virus spliced RNA proportion increases with liver disease
progression in patients with chronic hepatitis B.
J Med Virol. 2024;96:e29400. PubMedAbstract available
LIU W, Li L, Yin M, Cao C, et al High-speed centrifugation rather than Lipoclear reagent can be used for removing
the interference of lipemia on serological tests of infectious diseases: AIDS,
hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle
immunoassay.
J Med Virol. 2024;96:e29385. PubMedAbstract available
BLANCO S, Castro GM, Sicilia PE, Carrizo LH, et al Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An
emerging threat for transfusion safety in low-endemic countries?
J Med Virol. 2024;96:e29463. PubMedAbstract available
LIU Y, Kim ES, Guo H Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral
microbiota and immune microenvironment signatures.
J Med Virol. 2024;96:e29485. PubMedAbstract available
January 2024
SU YP, Lin SY, Su IJ, Kao YL, et al Characterization of integrated hepatitis B virus DNA harboring pre-S mutations in
hepatocellular carcinoma patients with ground glass hepatocytes.
J Med Virol. 2024;96:e29348. PubMedAbstract available
LI M, Wei Z, Su J, Wu X, et al Changing spectrum and mortality disparities of etiology of liver cirrhosis in
Beijing, China.
J Med Virol. 2024;96:e29405. PubMedAbstract available
ADHIKARI A, Abayasingam A, Brasher NA, Kim HN, et al Characterization of antibody-dependent cellular phagocytosis in patients infected
with hepatitis C virus with different clinical outcomes.
J Med Virol. 2024;96:e29381. PubMedAbstract available
PARK K, Kim J, Noh J, Kim K, et al First detection and characterization of hepatitis E virus (Rocahepevirus ratti)
from urban Norway rats (Rattus norvegicus) in the Republic of Korea.
J Med Virol. 2024;96:e29401. PubMedAbstract available
SHI J, Wang X, Qi W, Wang S, et al Association between NTCP hepatic expression and inflammation/fibrosis as well as
gender-specific differences in chronic HBV-infected patients.
J Med Virol. 2024;96:e29428. PubMedAbstract available
December 2023
PI Y, Li Y, Yan Q, Luo H, et al SPOP inhibits HBV transcription and replication by ubiquitination and degradation
of HNF1alpha.
J Med Virol. 2023;95:e29254. PubMedAbstract available
ABDEL-SAMIEE M, Youssef MI, Elghamry F, Bazeed M, et al A multicentric and nationwide predictive study role of T cell sub-population in
the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic
hepatitis C patients.
J Med Virol. 2023;95:e29248. PubMedAbstract available
LIANG YJ, Chiou YW, Chiu AP, Shiao MS, et al Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis
B virus replication may improve ER stress, mitochondrial and metabolic
dysfunctions and decrease p62 in hybridized mice with single HBV transgene and
miR-122.
J Med Virol. 2023;95:e29325. PubMedAbstract available
NGARI JW, Leumi S, Han L, Liu C, et al Identification and characterization of Sofosbuvir-resistant mutations of
hepatitis C virus genotype 3a replicon.
J Med Virol. 2023;95:e29290. PubMedAbstract available
NUERMAIMAITI A, Chang L, Yan Y, Sun H, et al The role of sex hormones and receptors in HBV infection and development of
HBV-related HCC.
J Med Virol. 2023;95:e29298. PubMedAbstract available
November 2023
KRUMBHOLZ A, Marcic A, Valentin M, Schemmerer M, et al Hepatitis A outbreak in a refugee shelter in Kiel, northern Germany.
J Med Virol. 2023;95:e29185. PubMedAbstract available
LI W, Zhang H, Ren A, Fan W, et al Systemic lupus erythematosus is associated with lower risk of hepatitis B virus
infection: A multivariable Mendelian randomization study in East Asian
population.
J Med Virol. 2023;95:e29226. PubMedAbstract available
WANG C, Zhang S, Zhao J, Wang M, et al Changes and gaps of global and regional disease burden of hepatitis B infection
in children younger than 5 years old between 2015 and 2019: A real-world data
review.
J Med Virol. 2023;95:e29241. PubMedAbstract available
LIM CK, Romeo O, Tran BM, Flanagan DJ, et al Assessment of hepatitis B virus infection and interhost cellular responses using
intrahepatic cholangiocyte organoids.
J Med Virol. 2023;95:e29232. PubMedAbstract available
October 2023
FU MX, Simmonds P, Andreani J, Baklan H, et al Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult
hepatitis B virus infection in English blood donors.
J Med Virol. 2023;95:e29144. PubMedAbstract available
WU WJ, Lin CL, Liu CJ, Huang YW, et al Lifetime risk of liver-related outcomes and determinants in male inactive
carriers of chronic hepatitis B.
J Med Virol. 2023;95:e29138. PubMedAbstract available
LIU J, Zhang H, Kong J, Liu S, et al Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis
B patients with immune control.
J Med Virol. 2023;95:e29173. PubMedAbstract available
ZHANG M, Chen S, Wu X, Zhou J, et al Persistent steatosis correlates with decreased fibrosis regression during
anti-HBV treatment in patients with chronic HBV infection.
J Med Virol. 2023;95:e29156. PubMedAbstract available
ZHAN Y, Tao Q, Lang Z, Lin L, et al Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and
monitoring liver fibrosis in chronic hepatitis B patients.
J Med Virol. 2023;95:e29157. PubMedAbstract available
ELIZALDE MM, Giadans CG, Campos RH, Flichman DM, et al Impact of core protein naturally selected mutants associated with HBeAg-negative
status in HBV biosynthesis.
J Med Virol. 2023;95:e29195. PubMedAbstract available
REN H, Chen X, Wang J, Chen Y, et al Temporal and structural patterns of hepatitis B virus integrations in
hepatocellular carcinoma.
J Med Virol. 2023;95:e29187. PubMedAbstract available
YANG D, Zou J, Guan G, Feng X, et al The A1762T/G1764A mutations enhance HBV replication by alternating viral
transcriptome.
J Med Virol. 2023;95:e29129. PubMedAbstract available
TANG L, Li Q, Chen L, Li X, et al IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV
infection.
J Med Virol. 2023;95:e29142. PubMedAbstract available
September 2023
SHEN Z, Zhang S, Jiang Q, Liu N, et al Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral
clearance in mouse models of hepatitis B virus persistence.
J Med Virol. 2023;95:e29062. PubMedAbstract available
PENG X, Shi Y, Zhang B, Xu C, et al Establishment of nucleic acid sensing pathways-based model in predicting response
to immunotherapy and targeted drug in hepatitis virus-related hepatocellular
carcinoma.
J Med Virol. 2023;95:e29084. PubMedAbstract available
SUZUKI T, Matsuura K, Watanabe T, Matsui T, et al Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic
hepatitis B patients with HBsAg seroclearance.
J Med Virol. 2023;95:e29109. PubMedAbstract available
LIU C, Guo M, Han L, Lu J, et al Construction and characterization of a new hepatitis C virus genotype 6a
subgenomic replicon that is prone to render the sofosbuvir resistance.
J Med Virol. 2023;95:e29103. PubMedAbstract available